Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Frampton

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Drugs|November 18, 2010
Olanzapine long-acting injection: a review of its use in the treatment of schizophreniaJames E Frampton
Drugs|August 25, 2010
Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute painJames E Frampton
Drugs|October 2, 2010
Cetuximab: a review of its use in squamous cell carcinoma of the head and neckJames E Frampton
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 23, 2015
Olaparib: a review of its use as maintenance therapy in patients with ovarian cancerJames E Frampton
CNS Drugs|July 3, 2015
Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs SyndromeJames E Frampton
CNS Drugs|May 21, 2021
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its UseJames E Frampton
Drugs|April 9, 2020
Eculizumab: A Review in Neuromyelitis Optica Spectrum DisorderJames E Frampton
Targeted Oncology|August 5, 2021
Isatuximab: A Review of Its Use in Multiple MyelomaJames E Frampton
Drugs|November 4, 2022
Darinaparsin: First ApprovalJames E Frampton
Drugs|October 5, 2022
Varenicline Solution Nasal Spray: A Review in Dry Eye DiseaseJames E Frampton
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Drugs|November 18, 2010
Olanzapine long-acting injection: a review of its use in the treatment of schizophreniaJames E Frampton
Drugs|August 25, 2010
Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute painJames E Frampton
Drugs|October 2, 2010
Cetuximab: a review of its use in squamous cell carcinoma of the head and neckJames E Frampton
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 23, 2015
Olaparib: a review of its use as maintenance therapy in patients with ovarian cancerJames E Frampton
CNS Drugs|July 3, 2015
Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs SyndromeJames E Frampton
CNS Drugs|May 21, 2021
Correction to: OnabotulinumtoxinA in Chronic Migraine: A Profile of Its UseJames E Frampton
Drugs|April 9, 2020
Eculizumab: A Review in Neuromyelitis Optica Spectrum DisorderJames E Frampton
Targeted Oncology|August 5, 2021
Isatuximab: A Review of Its Use in Multiple MyelomaJames E Frampton
Drugs|November 4, 2022
Darinaparsin: First ApprovalJames E Frampton
Drugs|October 5, 2022
Varenicline Solution Nasal Spray: A Review in Dry Eye DiseaseJames E Frampton
Pageof 14